Story perspectives
Moderna's CEO Blasts HHS's Covid Vaccine Policy Changes
9/10/2025
42 3
1 of 1
Story summary
- At the WIRED Health summit, Moderna CEO Stéphane Bancel criticized HHS Secretary Robert F. Kennedy, Jr.'s recent Covid-19 vaccine policy changes as a “step backward.”
- The FDA now limits Covid vaccine eligibility to high-risk individuals, making it harder for families to protect vulnerable members.
- Kennedy, opposing vaccines, ended a $590 million contract with Moderna for a bird flu vaccine.
- He stated mRNA vaccines are ineffective against respiratory infections, while HHS reallocates funding to whole-virus vaccines.
- Despite these challenges, Moderna gained expanded approval for its RSV vaccine and is advancing mRNA cancer therapies.
